IL2 and arthritic joint disease: Compared with phosphate-buffered saline (PBS) and NC siRNA control groups, administration of IL-2/15Rβ siRNA nanoparticles significantly reduced clinical signs of arthritis, as assessed by paw swelling and arthritis scores (Figure 5A).